Annual Accounts Payable
$3.78 M
+$1.39 M+58.08%
December 31, 2023
Summary
- As of February 7, 2025, FENC annual accounts payable is $3.78 million, with the most recent change of +$1.39 million (+58.08%) on December 31, 2023.
- During the last 3 years, FENC annual accounts payable has risen by +$2.21 million (+140.48%).
- FENC annual accounts payable is now at all-time high.
Performance
FENC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.87 M
-$580.00 K-13.04%
September 30, 2024
Summary
- As of February 7, 2025, FENC quarterly accounts payable is $3.87 million, with the most recent change of -$580.00 thousand (-13.04%) on September 30, 2024.
- Over the past year, FENC quarterly accounts payable has dropped by -$580.00 thousand (-13.04%).
- FENC quarterly accounts payable is now -25.69% below its all-time high of $5.20 million, reached on March 31, 2024.
Performance
FENC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FENC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +58.1% | -13.0% |
| 3 y3 years | +140.5% | +31.2% |
| 5 y5 years | +266.1% | +31.2% |
FENC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +386.2% | -25.7% | +397.7% |
| 5 y | 5-year | at high | +386.2% | -25.7% | +471.2% |
| alltime | all time | at high | +1682.1% | -25.7% | +2460.9% |
Fennec Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.87 M(-13.0%) |
| Jun 2024 | - | $4.45 M(-14.5%) |
| Mar 2024 | - | $5.20 M(+37.7%) |
| Dec 2023 | $3.78 M(+58.1%) | $3.78 M(+28.5%) |
| Sep 2023 | - | $2.94 M(-2.1%) |
| Jun 2023 | - | $3.00 M(+2.0%) |
| Mar 2023 | - | $2.95 M(+23.3%) |
| Dec 2022 | $2.39 M(+207.6%) | $2.39 M(-5.6%) |
| Sep 2022 | - | $2.53 M(+45.3%) |
| Jun 2022 | - | $1.74 M(+42.4%) |
| Mar 2022 | - | $1.22 M(+57.5%) |
| Dec 2021 | $777.00 K(-50.5%) | $777.00 K(-32.7%) |
| Sep 2021 | - | $1.15 M(+70.5%) |
| Jun 2021 | - | $677.00 K(-73.0%) |
| Mar 2021 | - | $2.51 M(+59.6%) |
| Dec 2020 | $1.57 M(-2.5%) | $1.57 M(-41.5%) |
| Sep 2020 | - | $2.68 M(-2.6%) |
| Jun 2020 | - | $2.75 M(+64.5%) |
| Mar 2020 | - | $1.68 M(+3.9%) |
| Dec 2019 | $1.61 M(+56.2%) | $1.61 M(+104.6%) |
| Sep 2019 | - | $788.00 K(-35.8%) |
| Jun 2019 | - | $1.23 M(-5.4%) |
| Mar 2019 | - | $1.30 M(+25.8%) |
| Dec 2018 | $1.03 M(+20.7%) | $1.03 M(-44.7%) |
| Sep 2018 | - | $1.87 M(+163.2%) |
| Jun 2018 | - | $709.00 K(-31.4%) |
| Mar 2018 | - | $1.03 M(+20.8%) |
| Dec 2017 | $855.00 K(+250.4%) | $855.00 K(+73.8%) |
| Sep 2017 | - | $492.00 K(+66.2%) |
| Jun 2017 | - | $296.00 K(+32.1%) |
| Mar 2017 | - | $224.00 K(-8.2%) |
| Dec 2016 | $244.00 K(-17.8%) | $244.00 K(+3.8%) |
| Sep 2016 | - | $235.00 K(-31.9%) |
| Jun 2016 | - | $345.00 K(+53.3%) |
| Mar 2016 | - | $225.00 K(-24.2%) |
| Dec 2015 | $297.00 K(-3.6%) | $297.00 K(+17.9%) |
| Sep 2015 | - | $252.00 K(-37.2%) |
| Jun 2015 | - | $401.00 K(+4.4%) |
| Mar 2015 | - | $384.00 K(+24.7%) |
| Dec 2014 | $308.00 K(+45.3%) | $308.00 K(-15.4%) |
| Sep 2014 | - | $364.00 K(+8.7%) |
| Jun 2014 | - | $335.00 K(+117.5%) |
| Mar 2014 | - | $154.00 K(-27.4%) |
| Dec 2013 | $212.00 K | $212.00 K(-32.7%) |
| Sep 2013 | - | $315.00 K(-56.0%) |
| Jun 2013 | - | $716.00 K(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $698.00 K(+169.5%) |
| Dec 2012 | $259.00 K(-24.3%) | $259.00 K(-17.8%) |
| Sep 2012 | - | $315.00 K(+14.1%) |
| Jun 2012 | - | $276.00 K(-26.2%) |
| Mar 2012 | - | $374.00 K(+9.4%) |
| Dec 2011 | $342.00 K(+25.7%) | $342.00 K(-17.4%) |
| Sep 2011 | - | $414.00 K(+73.2%) |
| Jun 2011 | - | $239.00 K(-45.9%) |
| Mar 2011 | - | $442.00 K(+62.5%) |
| Dec 2010 | $272.00 K(-14.5%) | $272.00 K(+74.4%) |
| Sep 2010 | - | $156.00 K(-47.1%) |
| Jun 2010 | - | $295.00 K(-12.7%) |
| Mar 2010 | - | $338.00 K(+6.3%) |
| Dec 2009 | $318.00 K(-41.9%) | $318.00 K(+13.2%) |
| Sep 2009 | - | $281.00 K(+86.1%) |
| Jun 2009 | - | $151.00 K(-78.0%) |
| Mar 2009 | - | $686.00 K(+25.4%) |
| Dec 2008 | $547.00 K(+2.8%) | $547.00 K(-44.7%) |
| Sep 2008 | - | $990.00 K(+52.5%) |
| Jun 2008 | - | $649.00 K(+26.5%) |
| Mar 2008 | - | $513.00 K(-3.6%) |
| Dec 2007 | $532.00 K(-74.3%) | $532.00 K(-1.7%) |
| Sep 2007 | - | $541.00 K(+18.4%) |
| Jun 2007 | - | $457.00 K(-43.5%) |
| Mar 2007 | - | $809.00 K(-61.0%) |
| Dec 2006 | $2.07 M(+49.7%) | $2.07 M(+85.0%) |
| Sep 2006 | - | $1.12 M(+71.1%) |
| Jun 2006 | - | $655.00 K(-39.6%) |
| Mar 2006 | - | $1.08 M(-21.7%) |
| Dec 2005 | $1.39 M(+117.9%) | $1.39 M(+24.1%) |
| Sep 2005 | - | $1.12 M(-23.9%) |
| Jun 2005 | - | $1.47 M(-7.2%) |
| Mar 2005 | - | $1.58 M(+14.9%) |
| Sep 2004 | - | $1.38 M(+42.4%) |
| Mar 2004 | - | $966.00 K(-19.6%) |
| Dec 2003 | - | $1.20 M(+83.0%) |
| Sep 2003 | - | $656.70 K(+3.9%) |
| Mar 2003 | - | $632.30 K(-25.3%) |
| Dec 2002 | - | $846.00 K(-6.4%) |
| Sep 2002 | - | $903.60 K(+42.2%) |
| Jun 2002 | $635.50 K(+44.0%) | $635.50 K(+37.6%) |
| Mar 2002 | - | $461.90 K(+14.8%) |
| Dec 2001 | - | $402.40 K(+6.6%) |
| Sep 2001 | - | $377.60 K(-14.4%) |
| Jun 2001 | $441.30 K(+4.2%) | $441.30 K(+13.4%) |
| Dec 2000 | - | $389.30 K |
| Jun 2000 | $423.50 K | - |
FAQ
- What is Fennec Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual accounts payable year-on-year change?
- What is Fennec Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly accounts payable year-on-year change?
What is Fennec Pharmaceuticals annual accounts payable?
The current annual accounts payable of FENC is $3.78 M
What is the all time high annual accounts payable for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual accounts payable is $3.78 M
What is Fennec Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, FENC annual accounts payable has changed by +$1.39 M (+58.08%)
What is Fennec Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of FENC is $3.87 M
What is the all time high quarterly accounts payable for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly accounts payable is $5.20 M
What is Fennec Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, FENC quarterly accounts payable has changed by -$580.00 K (-13.04%)